Catapult Ventures

Catapult Ventures is a venture capital investment firm founded in 1999 and based in Leicester, United Kingdom. The firm focuses on a diverse array of sectors, including healthcare, medical devices, environmental technologies, luxury consumer brands, manufacturing, and software. Catapult Ventures is distinguished by its team of highly experienced investors, who have extensive backgrounds in both early-stage and established companies. This expertise encompasses various phases of business development, from start-ups and pre-revenue intellectual property developers to companies preparing for public flotation and those generating substantial revenues. The administration team at Catapult Ventures also brings over a decade of experience in the venture capital sector, further enhancing the firm's capabilities in identifying and supporting promising investment opportunities.

Duncan Cameron

CFO

Rob Carroll

Director

Vijay Curthan

Investment Director

Nick Wright

CEO

105 past transactions

Pickle Robot

Series B in 2024
Pickle Robot Company, founded in 2018 and based in Cambridge, Massachusetts, develops an innovative package handling robot designed to automate critical tasks in the e-commerce supply chain. The company's first robot, named Dill, addresses the physically demanding nature of package handling, which often results in high employee turnover. Dill is capable of performing multiple shifts and effectively communicates with human workers, continuously developing new skills to enhance operations. The robot's capabilities include loading and unloading feeder trucks, palletizing and depalletizing mixed parcels, preloading last-mile delivery vehicles, and sorting packages. By automating these processes, Pickle Robot aims to help logistics companies reduce labor costs and increase efficiency, addressing a significant bottleneck in the rapidly growing e-commerce sector.

Path Robotics

Series D in 2024
Path Robotics, Inc., based in Cleveland, Ohio, specializes in the manufacture of autonomous welding robots. Founded in 2018, the company focuses on designing robotic welding systems that utilize artificial intelligence and machine learning to enhance precision and adaptability in manufacturing processes. These advanced systems automate repetitive welding tasks, helping manufacturers boost productivity while reducing initial costs. By addressing workforce challenges in the manufacturing sector, Path Robotics offers effective automation solutions that streamline operations. Their robots are engineered to autonomously locate and weld seams, significantly reducing production time and improving quality by minimizing errors and inconsistencies. This technology enables industries to simplify their production processes and enhance overall efficiency.

CroBio

Seed Round in 2024
CroBio Ltd is an agricultural biotechnology company based in Macclesfield, United Kingdom, founded in 2019 by experts in microbiology and engineering. The company focuses on developing environmentally sustainable solutions to combat global agricultural drought. Its technology leverages genetically engineered root-associated bacteria that produce a sponge-like biomaterial, facilitating biologically active water retention in soil. This innovative approach aims to improve soil health and enhance water management in agricultural practices.

Pencil Biosciences

Seed Round in 2023
Pencil Biosciences is focused on creating an innovative genome modulation platform that addresses the limitations of existing gene-editing technologies. By developing a programmable tool for genome modulation, the company aims to provide new therapeutic options for patients suffering from rare diseases. This technology is designed to have a broad impact, allowing medical professionals to navigate the complexities of gene editing more effectively. Through its advancements, Pencil Biosciences seeks to enhance the capabilities of gene-editing applications in the medical field.

QV Bioelectronics

Seed Round in 2023
QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

Urban Machine

Seed Round in 2022
Urban Machine is a construction company focused on the reclamation and repurposing of wood waste from demolition and new construction sites. By utilizing advanced robotics and artificial intelligence, the company efficiently removes nails, screws, and staples from reclaimed wood, transforming it into high-quality, locally sourced premium lumber products. Urban Machine aims to promote sustainability within the construction industry by providing a viable alternative to virgin lumber, thereby reducing waste and minimizing environmental impact. Through its innovative approach, the company supports a more sustainable future by contributing to the circular economy in the building sector.

Pickle Robot

Series A in 2022
Pickle Robot Company, founded in 2018 and based in Cambridge, Massachusetts, develops an innovative package handling robot designed to automate critical tasks in the e-commerce supply chain. The company's first robot, named Dill, addresses the physically demanding nature of package handling, which often results in high employee turnover. Dill is capable of performing multiple shifts and effectively communicates with human workers, continuously developing new skills to enhance operations. The robot's capabilities include loading and unloading feeder trucks, palletizing and depalletizing mixed parcels, preloading last-mile delivery vehicles, and sorting packages. By automating these processes, Pickle Robot aims to help logistics companies reduce labor costs and increase efficiency, addressing a significant bottleneck in the rapidly growing e-commerce sector.

Strella Biotechnology

Series A in 2022
Strella Biotechnology, Inc. is a Philadelphia-based company that designs and manufactures sensor-based devices aimed at maximizing the freshness of produce throughout the supply chain. Founded in 2018 by Jacob Jordan and Katherine Sizov, the company specializes in ethylene detection technology, which assesses the ripeness of fruit by measuring the ethylene gas emitted during ripening. This innovation helps to optimize the produce supply chain by providing critical data that reduces spoilage and enhances the management of fresh produce. Strella Biotechnology leverages its patented technology to support efficiency and maintain quality in food distribution.

Urban Machine

Pre Seed Round in 2021
Urban Machine is a construction company focused on the reclamation and repurposing of wood waste from demolition and new construction sites. By utilizing advanced robotics and artificial intelligence, the company efficiently removes nails, screws, and staples from reclaimed wood, transforming it into high-quality, locally sourced premium lumber products. Urban Machine aims to promote sustainability within the construction industry by providing a viable alternative to virgin lumber, thereby reducing waste and minimizing environmental impact. Through its innovative approach, the company supports a more sustainable future by contributing to the circular economy in the building sector.

Viscgo

Venture Round in 2021
Viscgo Limited is a company based in Warrington, United Kingdom, founded in 2015. It specializes in designing, developing, and delivering innovative devices and technology aimed at improving the management of dysphagia, a condition that affects individuals with swallowing disorders. Viscgo's product line includes drink thickness testers that enable accurate measurement of the viscosity of various liquids and textured-modified foods. This technology aids patients, caregivers, and clinicians by ensuring that fluids are properly mixed to provide a smooth consistency, thereby enhancing the safety and quality of care in settings such as hospitals, care homes, schools, and nurseries.

Maxwellia

Venture Round in 2021
Maxwellia Ltd is a UK-based company specializing in converting prescription medications into over-the-counter (OTC) products, allowing consumers to manage their health without a doctor's prescription. Founded in 2013 and located in Alderley Edge, the company employs a comprehensive approach to "switching" medications, which includes identifying potential drug candidates, assessing market opportunities, and guiding the development process from concept to market launch. Its services encompass the SwitchScreen, which evaluates existing prescription drugs for potential OTC conversion; SwitchUp, which designs the switching strategy and assesses risks; and SwitchAbility, which supports the entire process to ensure successful commercialization. By repurposing established prescription drugs into branded OTC products, Maxwellia aims to enhance self-care options for consumers and create new therapeutic brands available in pharmacies, supermarkets, and online.

Camect

Pre Seed Round in 2020
Camect, Inc. specializes in developing and selling advanced video surveillance technologies designed for both residential and commercial use. The company offers Camect Home, a smart security camera that features 24/7 local recording and AI-powered alert detection, as well as Camect Go, a web app subscription service that allows users to access their camera feeds remotely. This service includes features such as email alerts, app notifications, cloud storage for motion videos, and the ability to share content with others. Camect's system is compatible with a wide range of camera brands, providing users with enhanced alert capabilities and a user-friendly interface, all while ensuring local data privacy. Established in 2017 and based in Mountain View, California, Camect aims to provide a comprehensive and cost-effective security solution.

Strella Biotechnology

Seed Round in 2020
Strella Biotechnology, Inc. is a Philadelphia-based company that designs and manufactures sensor-based devices aimed at maximizing the freshness of produce throughout the supply chain. Founded in 2018 by Jacob Jordan and Katherine Sizov, the company specializes in ethylene detection technology, which assesses the ripeness of fruit by measuring the ethylene gas emitted during ripening. This innovation helps to optimize the produce supply chain by providing critical data that reduces spoilage and enhances the management of fresh produce. Strella Biotechnology leverages its patented technology to support efficiency and maintain quality in food distribution.

Left Hand Robotics

Series A in 2019
Left Hand Robotics, Inc. specializes in developing commercial-grade robots designed for outdoor labor-intensive tasks. The company's flagship product, the RT-1000 ROBOT, is a fully autonomous workbot capable of mowing grass and clearing snow. It can be equipped with various attachments, including a MOWER DECK for cutting large grassy areas, a SNOW BROOM for snow removal, and a DEICER BOX for treating icy sidewalks and bike paths. The robots are controlled and monitored via an online management dashboard, utilizing GPS for navigation along pre-programmed paths. Founded in 2016 and based in Longmont, Colorado, Left Hand Robotics aims to enhance efficiency and reduce labor costs in outdoor maintenance tasks.

Advanced Farm Technologies

Series A in 2019
Advanced Farm Technologies Inc. is a robotics company specializing in strawberry harvesting services in the Oxnard, Santa Maria, and Salinas-Watsonville regions of California. Founded in 2017 and based in Davis, the company focuses on utilizing advanced robotics to improve the efficiency and quality of strawberry harvesting. Its robotic systems are designed to handle berries delicately, minimizing bruising and damage during the picking process. By integrating technology into agriculture, Advanced Farm Technologies aims to enhance farm productivity while maintaining the quality of the harvested fruit.

Rinicare

Venture Round in 2018
Rinicare Ltd. is a healthcare technology company based in Macclesfield, United Kingdom, that specializes in designing and manufacturing innovative monitoring devices. The company produces the PRIME device, which offers vital sign monitoring and data analysis through wireless sensors, allowing clinicians to remotely access, transmit, and store patient information. Additionally, Rinicare develops the PRIME IoT, which facilitates data transmission to compatible devices via healthcare application software. The company also offers a falls detection and prevention system called SAFE, utilizing thermal imaging sensors and intelligent algorithms to monitor patients’ risk of falling in real-time. Alongside these devices, Rinicare creates application software that tracks comprehensive patient data, enhancing clinical risk prediction and improving patient care outcomes. Established in 2002, Rinicare aims to integrate its solutions seamlessly into existing healthcare infrastructures to support timely and informed decision-making by clinicians.

Renephra

Seed Round in 2018
Renephra Ltd. is a medical device company based in Manchester, United Kingdom, established in 2009. It specializes in developing innovative Transdermal Fluid Removal (TFR) technology aimed at addressing fluid overload and chronic conditions such as oedema and lymphoedema. The company's devices utilize a micro-needle system combined with negative pressure therapy to facilitate minimally invasive fluid removal from the skin. This technology targets significant clinical needs within vascular and oncology patients, representing a large and underserved market estimated at £1 billion globally. Having achieved proof of concept in human trials, Renephra is currently seeking funding to advance its device development and feasibility studies.

Acea Health

Seed Round in 2018
Acea Health is a digital healthcare company developing an application called Flynotes - a new digital consent platform. Flynotes analyses a number of factors, including the patient’s background, to deliver personalised risks and benefits. Flynotes aims to be the go-to solution for consent in healthcare. .

metaLinear

Seed Round in 2017
metaLinear Ltd. is a biotechnology company based in Alderley Edge, United Kingdom, founded in 2016. The company specializes in the engineering of microbial proteomes to identify and validate novel targets for anti-infective drug discovery, specifically aimed at difficult-to-treat bacterial infections. Utilizing a proprietary proteome engineering platform, metaLinear creates extensive libraries of randomized proteins, known as R-teins, which are expressed in target bacteria. This innovative approach allows for the screening and characterization of new antibiotic targets, effectively de-risking the target identification process and improving the efficiency of traditional drug discovery workflows. Through its efforts, metaLinear aims to provide drug developers with effective solutions to overcome various challenges in developing new microbial drugs.

MicroBioSensor

Venture Round in 2017
MicroBioSensor is a diagnostics company focused on developing disposable point-of-care medical devices for the early detection of bacterial infections. The company specializes in creating user-friendly tests and safety monitors that can be utilized by untrained personnel in settings such as care homes, pharmacies, and general practitioner practices. Its initial efforts are directed towards improving early infection detection for patients undergoing peritoneal dialysis and facilitating the detection and appropriate antibiotic selection for suspected urinary tract infections. By embedding its innovative solutions in existing medical devices, MicroBioSensor aims to enhance patient care and enable earlier medical interventions at a low cost.

Elucid mHealth

Series A in 2017
Elucid mHealth Limited is a medication technology company based in Manchester, United Kingdom, focused on enhancing clinical trial efficiencies through innovative adherence monitoring tools. Incorporated in 2013, the company developed Pill Connect, a sophisticated pill bottle that facilitates real-time remote monitoring of medication adherence. This product allows trial organizers to access vital data on patient dosing, including missed doses, new doses, and overall engagement metrics. By providing a feedback system that connects individual user doses to provider monitoring systems, Elucid mHealth aims to improve the accuracy and efficiency of clinical trials while addressing non-adherence issues.

Proveca

Venture Round in 2017
Proveca Ltd. is a pharmaceutical company based in Daresbury, United Kingdom, that specializes in identifying, researching, and licensing off-patent medicines aimed at addressing unmet healthcare needs in the pediatric market. Founded in 2010, Proveca focuses on developing formulations and clinical data necessary to obtain Pediatric Use Marketing Authorisation (PUMA) for its products, which include treatments for conditions such as sialorrhoea, epilepsy, heart failure, and acute pain. The company seeks to secure market protection and exclusivity for its medicines by pursuing PUMA and, where applicable, Orphan Drug status. By doing so, Proveca aims to ensure that its licensed medicines are commercially viable and beneficial for children, either through direct commercialization or by selling the licenses to larger pharmaceutical firms.

AMR Centre

Venture Round in 2017
AMR Centre Limited is focused on addressing the challenge of antimicrobial resistance through the development of new antibiotics. Established in 2016 and located in Macclesfield, United Kingdom, the company offers development services to organizations globally, partnering with them to expedite the creation of innovative antibiotic solutions. In return for these services, AMR Centre receives a commercial share from the newly developed products. Through its efforts, the company aims to contribute significantly to the fight against drug-resistant infections, improving healthcare outcomes worldwide.

Apex Molecular

Venture Round in 2016
Apex Molecular Ltd is a synthetic chemistry company based in Alderley Edge, United Kingdom, specializing in laboratory-scale chemistry services for the pharmaceutical, biotechnology, and applied chemistry sectors. Established in 2008 and rebranded from YProTech Ltd in 2019, the company offers a range of development services, including high potency synthesis, custom synthesis, and project scale-up. Apex Molecular caters to clients in drug discovery, biotechnology, and agritech, delivering services that are timely, reliable, and cost-effective. By employing a flexible approach to project design, the company aims to assist its clients in managing their project portfolios with minimal risk and time delays.

SwabTech

Seed Round in 2016
SwabTech Ltd is a UK-based medical device company that originated from the National Health Service (NHS) to create an automated swab washing device aimed at enhancing intra-operative cell salvage in surgical settings. The company is focused on developing a patented Surgical Swab Washer that automates the extraction of blood from surgical swabs, a task traditionally performed manually. This device allows for the recovery and reuse of blood during high blood loss surgeries, facilitating autologous transfusions directly in the operating theatre. By enabling the timely retrieval of blood for processing and transfusion back to patients, SwabTech's innovation aims to improve clinical outcomes while also offering a cost-effective solution for hospitals.

Blueberry Therapeutics

Venture Round in 2016
Blueberry Therapeutics Ltd. specializes in the development of therapies for diseases characterized by infection and inflammation, with a particular focus on dermatological disorders. Founded in 2011 and based in Alderley Edge, United Kingdom, the company utilizes a nano polymer drug delivery platform to enhance the delivery of small molecules and biologics directly into cells and tissues. Its research and development efforts are aimed at creating effective treatments for conditions such as inflammatory bowel disease, atopic dermatitis, acne, and wound healing. By concentrating on well-validated drug targets and ensuring low toxicity levels in candidate molecules, Blueberry Therapeutics aims to address significant challenges in drug development and improve patient outcomes.

Biorelate

Seed Round in 2016
Biorelate Ltd. is a biomedical research services company based in Oldham, United Kingdom, founded in 2014. The company focuses on the research and development of biomarkers for diagnosing prostate cancer, target validation, and drug development. Biorelate has developed a database platform that curates biomedical knowledge to support innovations in biotechnological research. Its platform is designed to automatically curate valuable biomedical data from various text sources, ingest information from multiple origins, and identify causal interactions between genes, chemicals, drugs, cells, and phenotypes. This functionality enhances the capabilities of scientists engaged in drug discovery and cancer diagnosis, facilitating their research efforts.

Kanichi Research Services

Venture Round in 2016
Kanichi Research Services specializes in the development of innovative non-invasive diagnostic systems that analyze exhaled breath for the rapid identification and diagnosis of various diseases. Their flagship product is an affordable, disposable point-of-care test targeting Helicobacter Pylori, a bacterial infection associated with stomach ulcers and cancer. In addition to diagnostic tests, the company designs bespoke electrochemical components, including custom-made electrodes, for use in advanced sensor systems. These components facilitate the detection of a wide range of chemical and biological molecules across air, breath, and liquid media, enhancing the capabilities of their diagnostic offerings.

Arlabion

Seed Round in 2016
Arlabion Ltd is an agri-tech company based in Huddersfield, United Kingdom, focused on developing innovative agrochemicals for sustainable crop management. Founded in 2014, Arlabion specializes in a novel seed treatment designed to protect crops from fungal infections. This technology enhances the plant immune system, improves seed germination, and promotes root system development, thereby reducing the risk of fungal diseases. Targeting a growing market for safer agricultural solutions, Arlabion applies established organic chemistry techniques, typically used in human and animal healthcare, to agriculture. The company's approach aims to provide effective and less harmful alternatives for addressing fungal infections in essential food crops.

Monica Healthcare

Seed Round in 2015
Monica Healthcare specializes in the manufacturing and supply of advanced fetal monitoring devices aimed at improving obstetric care for midwives, labor and delivery nurses, and expectant mothers. The company’s flagship product, The Novii, is a single-use wireless patch system that monitors maternal heart rate, fetal heart rate, and uterine activity, enhancing the birthing experience. Additionally, Monica Healthcare develops a range of wearable devices that utilize innovative wireless technologies to provide accessible obstetric services both in hospitals and at home. The company also offers training, repairs, and support services for its products. Established in 2005 and headquartered in Nottingham, United Kingdom, with a location in Kennesaw, Georgia, Monica Healthcare operates as a subsidiary of GE Healthcare.

Michelson Diagnostics

Series A in 2014
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

4Energy

Corporate Round in 2013
4energy, based in Nottingham, specializes in innovative cooling solutions that significantly enhance energy efficiency, achieving up to 50% savings compared to traditional cooling systems. The company has developed an IoT software platform that integrates data from various meters, regardless of vendor, to provide a centralized overview of utility usage. This platform is designed for application in industrial and commercial environments, including data centers, communication rooms, and base stations. By facilitating network-free cooling and demand-side response initiatives, 4energy's solutions aim to optimize energy consumption in the data center and telecommunications sectors.

Activ8 Intelligence

Venture Round in 2013
Activ8 Intelligence Limited specializes in providing human resources reporting, analytics, and predictive solutions aimed at enhancing workforce management and business outcomes. The company offers a range of services, including HR reporting tools that deliver key performance indicators, dashboards, and analytical reports. Its analytics solutions, such as doogle and trend analyzers, enable organizations to interpret data effectively. Additionally, Activ8 provides predictive solutions that facilitate workforce planning, recruitment, and talent management decisions. The company also offers human capital consultancy services, data analysis, and metrics design, helping organizations translate complex data into actionable insights. Established in 2005 and based in Farnsfield, United Kingdom, Activ8 Intelligence was previously known as active8 Human Resources Limited before rebranding in 2007. As of September 2016, it operates as a subsidiary of Liaison Financial Services Limited.

Haemostatix

Venture Round in 2012
Haemostatix Ltd., founded in 2003 and based in Nottingham, United Kingdom, specializes in developing a peptide-based platform technology aimed at addressing surgical bleeding and advancing tissue repair and regenerative medicine. The company originated as a spin-out from the University of Leicester and was co-founded by Sarah Middleton and Professor Alison Goodall. Its product pipeline includes PeproStat, a coagulant applied directly to wounds to effectively manage bleeding during surgical procedures. Haemostatix also focuses on creating various forms of hemostats, including liquid and transparent gel formulations, which enhance the speed and safety of bleeding control for healthcare professionals. As of May 2016, Haemostatix operates as a subsidiary of Ergomed plc.

Biofortuna

Venture Round in 2012
Biofortuna Limited is a molecular diagnostics company based in Wirral, United Kingdom, founded in 2008. The company specializes in the development and manufacture of freeze-dried HLA molecular diagnostic kits, including its SSPGo solution for genotyping and Verdict software for analyzing test results. Biofortuna's products cater to various applications, such as companion diagnostics, clinical testing, bio-defense, and food and veterinary diagnostics. Additionally, the company provides contract development and manufacturing services for cryo-preservatives and IVD kits, as well as custom assay development for clients in healthcare. Biofortuna's innovative technology allows for the transformation of PCR tests into freeze-dried formats, enhancing the stability and usability of molecular reagents. The company's offerings serve a global customer base through a network of distributors.

Echo

Venture Round in 2012
Echo Ltd. is a company that specializes in providing a comprehensive range of IT and logistical support services through an outsourced partnership model. Established in 2010 and headquartered in Oklahoma City, Oklahoma, the firm focuses on delivering tailored solutions that enhance existing service portfolios, thereby improving cost efficiency while upholding high-quality service standards. Additionally, Echo Investment Capital, the corporate venture capital arm of Echo Energy, seeks investment opportunities in various sectors, including life sciences, technology, media, education, and real estate.

Comply Serve

Venture Round in 2012
Comply Serve Limited is a software company based in Solihull, United Kingdom, specializing in assurance and compliance solutions for highly regulated industries, including rail, aviation, energy, and infrastructure. Founded in 2005, the company developed ComplyPro, a cloud-based platform designed for large-scale infrastructure projects. This platform facilitates compliance monitoring throughout the project lifecycle, ensuring that design, build, and delivery processes adhere to agreed specifications. ComplyPro promotes collaborative working between clients and their supply chains, enhancing governance over assurance processes. By enabling engineering and delivery teams to manage compliance effectively, the software helps project sponsors make informed decisions, ultimately reducing project failure risks and improving overall outcomes. As of November 2016, Comply Serve operates as a subsidiary of Bentley Systems, Incorporated.

Michelson Diagnostics

Venture Round in 2012
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

BioFilm

Venture Round in 2012
BioFilm Limited specializes in designing, developing, and manufacturing thin dissolvable films for various applications in the nutritional supplement, cosmetic, dental, and medical markets across Europe. The company's product range includes oral care films such as teeth whitening strips and mouth ulcer patches, as well as food supplement films containing ingredients like potassium iodide, caffeine, and melatonin. Additionally, BioFilm produces films for skin lightening, wound care, pharmaceuticals, and breath fresheners. The company operates as a private label developer and manufacturer, providing tailored film products for oral care, skin care, food supplements, and over-the-counter drugs to pharmaceutical, consumer goods, and retail industries. Founded in 2003 and based in Glasgow, United Kingdom, BioFilm has established a state-of-the-art manufacturing facility and has secured supply agreements with several key customers.

Stage Coach

Acquisition in 2012
Stagecoach is a network of performing arts schools that teaches children and young people to sing, dance and act in a fun, educational, and stimulating environment

Biofortuna

Venture Round in 2012
Biofortuna Limited is a molecular diagnostics company based in Wirral, United Kingdom, founded in 2008. The company specializes in the development and manufacture of freeze-dried HLA molecular diagnostic kits, including its SSPGo solution for genotyping and Verdict software for analyzing test results. Biofortuna's products cater to various applications, such as companion diagnostics, clinical testing, bio-defense, and food and veterinary diagnostics. Additionally, the company provides contract development and manufacturing services for cryo-preservatives and IVD kits, as well as custom assay development for clients in healthcare. Biofortuna's innovative technology allows for the transformation of PCR tests into freeze-dried formats, enhancing the stability and usability of molecular reagents. The company's offerings serve a global customer base through a network of distributors.

Oracle Care & Education

Venture Round in 2011
Oracle Care & Education specializes in providing comprehensive education and therapeutic residential care services for young people aged ten to eighteen with complex needs. Operating primarily in Staffordshire and Bedfordshire, the organization focuses on creating a supportive and safe environment that fosters positive relationships and builds self-esteem. By offering a holistic approach to care and education, Oracle Care aims to empower children, helping them to achieve a better future.

Hangar Seven

Venture Round in 2011
Hangar Seven Limited is a creative production business that offers marketing services to retailers and consumer brands globally. Established in 2007 and headquartered in Macclesfield, United Kingdom, with additional facilities in London, South Manchester, Leeds, and Portugal, the company provides a comprehensive range of services including asset management, creative production, digital marketing, packaging, photography, and retail marketing. Hangar Seven specializes in content strategy, creation, management, and distribution, effectively engaging consumers through various channels such as point of sale, social media, and digital advertising. The company operates large studios for photography and produces a variety of marketing materials, including flyers and catalogues, for distribution across over 87 countries. As of 2017, Hangar Seven operates as a subsidiary of The Hut.com Ltd.

5Degrees

Seed Round in 2011
5Degrees is a company that creates mobile and web-based customer relationship management (CRM) tools tailored for startups and small businesses. Founded in June 2011 and based in Chicago, Illinois, 5Degrees offers a range of products, including 5Degrees CRM, an iPhone CRM app, and Networker, a business card scanning application. These tools allow users to import contacts from various sources, organize their networks, and maintain communication through features such as note-taking, templated emails, and task scheduling. The platform also includes integrations with LinkedIn and Box.com, enabling seamless multi-device synchronization and offline access. By focusing on essential aspects of relationship building, 5Degrees helps clients log various forms of communication and maintain detailed records of their interactions, ultimately supporting their sales growth.

Haemostatix

Series C in 2011
Haemostatix Ltd., founded in 2003 and based in Nottingham, United Kingdom, specializes in developing a peptide-based platform technology aimed at addressing surgical bleeding and advancing tissue repair and regenerative medicine. The company originated as a spin-out from the University of Leicester and was co-founded by Sarah Middleton and Professor Alison Goodall. Its product pipeline includes PeproStat, a coagulant applied directly to wounds to effectively manage bleeding during surgical procedures. Haemostatix also focuses on creating various forms of hemostats, including liquid and transparent gel formulations, which enhance the speed and safety of bleeding control for healthcare professionals. As of May 2016, Haemostatix operates as a subsidiary of Ergomed plc.

KickSport

Venture Round in 2011
KickSport is an online retailer that specializes in martial arts equipment and uniforms, catering to disciplines such as Judo, Karate, and Taekwondo. The company is committed to delivering high-quality products alongside exceptional customer service. In addition to martial arts gear, KickSport also offers equipment for boxing, wrestling, and other physical sports, providing a diverse selection of assured quality items through its platform. The business emphasizes values such as energy, dedication, leadership, evolution, aspiration, community, fashion, and quality, reflecting its dedication to both customers and the sports community.

Intelligent Orthopaedics

Venture Round in 2011
Intelligent Orthopaedics, based in Newcastle-under-Lyme, United Kingdom, specializes in the design, development, and manufacture of orthopedic trauma devices aimed at treating tibial fractures. The company is known for its innovative products, including the STORM (The Staffordshire Orthopaedic Reduction Machine), a reusable surgical device designed for fracture reduction, and IOS, a single-use fixator intended for unstable tibial shaft fractures. Intelligent Orthopaedics focuses on providing advanced solutions that enhance surgical outcomes and improve patient care in orthopedic trauma. The company was incorporated in 2002. However, as of September 2016, it has entered liquidation.

Haemostatix

Venture Round in 2010
Haemostatix Ltd., founded in 2003 and based in Nottingham, United Kingdom, specializes in developing a peptide-based platform technology aimed at addressing surgical bleeding and advancing tissue repair and regenerative medicine. The company originated as a spin-out from the University of Leicester and was co-founded by Sarah Middleton and Professor Alison Goodall. Its product pipeline includes PeproStat, a coagulant applied directly to wounds to effectively manage bleeding during surgical procedures. Haemostatix also focuses on creating various forms of hemostats, including liquid and transparent gel formulations, which enhance the speed and safety of bleeding control for healthcare professionals. As of May 2016, Haemostatix operates as a subsidiary of Ergomed plc.

Oxford Cryosystems

Acquisition in 2010
Oxford Cryosystems Ltd is a manufacturer and exporter of specialized scientific cooling instrumentation and related software, known for its product lines Cryostream Plus and Cryostream Compact. The company develops low-temperature systems utilized in X-ray crystallography, including Cryostream Coolers and open-flow coolers for various sample types. Additionally, it produces cryocoolers for applications in radioastronomy and magnet cooling, as well as Coolstar coldheads and Cryodrive helium compressors. Its software, Crystallographica, aids in research and analysis in crystallography. Founded in 1964 and based in Oxford, United Kingdom, Oxford Cryosystems originated from a laboratory at Oxford University in the 1980s and has since evolved into a market leader in its field. The company serves a diverse clientele, including universities, high-tech manufacturers, drug companies, and research institutes, with a significant portion of its production exported globally while maintaining a strong reliance on British suppliers.

nanoTherics

Venture Round in 2010
nanoTherics Limited is a company based in Stoke-on-Trent, United Kingdom, that specializes in developing scientific devices and products for research laboratories in the biotechnology, life science, and pharmaceutical sectors. Founded in 2007, nanoTherics offers advanced technologies such as the magneTherm for magnetic fluid and nanoparticle hyperthermia testing, and live cell alternating magnetic field exposure systems for in vitro imaging. Their product line includes magnetic nanoparticles and lipid-based transfection reagents designed for applications in drug screening, gene therapy, and bioseparation. The company’s gene transfection technology has demonstrated significant performance improvements over existing non-viral techniques, allowing for high transfection rates while preserving cell viability, thus positioning it as a competitive alternative in the market. Through its innovative solutions, nanoTherics aims to support the development of therapies for genetic disorders and diseases such as cancer and Parkinson's. The company also provides its products for sale online.

Yospace Technologies

Venture Round in 2010
Yospace Technologies is a provider of innovative solutions for mobile video services, specializing in server-side advertisement insertion for live and on-demand streaming. Founded in 1999 and based in Staines-upon-Thames, United Kingdom, the company serves digital publishers, mobile application developers, and mobile operators, helping them deliver video content efficiently and affordably. Yospace's technology facilitates intelligent streaming and dynamic ad insertion, allowing content owners to maximize monetization through tailored advertising. Its flagship product, yospaceCDS, is a versatile platform that supports live and on-demand video services with in-stream ad integration. Additionally, Yospace offers a range of broadcast solutions to enhance stream conditioning and manage ad avail detection, ensuring seamless ad placements and effective audience targeting without disrupting existing workflows.

Silver Lining Solutions

Venture Round in 2010
Silver Lining Solutions Limited specializes in employee performance optimization software tailored for international call centers. The company’s innovative solutions enhance employee engagement and performance by identifying individual skills and knowledge, ensuring that customer inquiries are directed to the most qualified personnel. Their software suite includes tools for diagnosing performance issues, scheduling assessments, importing performance data, and generating customized development plans to address skill gaps. Additionally, it facilitates various training methods such as e-learning, coaching, and team meetings. Founded in 1999 and headquartered in Solihull, United Kingdom, Silver Lining Solutions also maintains offices in Asia Pacific and the United States. The company has established strategic partnerships with notable organizations in the telecommunications sector, enhancing its ability to deliver impactful solutions. As of February 2017, Silver Lining Solutions operates as a subsidiary of Genesys Telecommunications Laboratories, Inc.

Renewable Technical Services Limited

Venture Round in 2010
Renewable Technical Services Limited is a provider of installation, repair and maintenance services to the wind energy sector. The company supports major OEMs under preferred supplier / framework agreements, as well as working for the major power companies and wind-farm operators under long-term arrangements. With over 20 years of experience in installation and maintenance of met masts and wind turbines, the RTS team is available 24 hours a day, 7 days a week to support the wind energy industry. Having provided services to over 268 wind farms in the UK, it has worked on over 5,000 wind turbines. Our reach extends further still, with RTS engineers having worked on contracts in New Zealand, the Dominican Republic, Libya, South Africa and throughout Europe.

Biofortuna

Venture Round in 2010
Biofortuna Limited is a molecular diagnostics company based in Wirral, United Kingdom, founded in 2008. The company specializes in the development and manufacture of freeze-dried HLA molecular diagnostic kits, including its SSPGo solution for genotyping and Verdict software for analyzing test results. Biofortuna's products cater to various applications, such as companion diagnostics, clinical testing, bio-defense, and food and veterinary diagnostics. Additionally, the company provides contract development and manufacturing services for cryo-preservatives and IVD kits, as well as custom assay development for clients in healthcare. Biofortuna's innovative technology allows for the transformation of PCR tests into freeze-dried formats, enhancing the stability and usability of molecular reagents. The company's offerings serve a global customer base through a network of distributors.

Oxford Biotherapeutics

Venture Round in 2010
Oxford BioTherapeutics Ltd is a biotechnology company specializing in the development of targeted antibody-drug conjugates for cancer treatment. Utilizing its proprietary OGAP platform, which is one of the largest human protein databases, the company identifies a range of validated and novel antigen targets from various cancer types. Its leading product, OBT076, is an antibody-drug conjugate aimed at treating high-risk HER2 negative breast cancer, as well as other solid tumors such as gastric, lung, bladder, and ovarian cancers. In addition to its cancer therapies, Oxford BioTherapeutics is also engaged in developing antibody-based treatments for acute myeloid leukemia. The company has formed strategic collaborations with prominent antibody firms to enhance its pipeline of novel therapeutics. Established in 2003 and based in Oxon, United Kingdom, with a presence in San Jose, California, Oxford BioTherapeutics aims to improve patient outcomes through innovative treatments and the integration of companion diagnostics into its development processes.

Zinwave

Funding Round in 2010
Zinwave UK is a global provider of wideband active distributed antenna systems that enhance in-building wireless coverage. The company manufactures patented ultra-wideband radio frequency fiber solutions tailored for various sectors, including commercial real estate, healthcare, hospitality, enterprise, public venues, wholesale data centers, and education. Zinwave's products and services focus on optimizing connectivity for mobile network operators, integrators, and end users through its innovative wideband technology.

Intellitect Water Holdings

Venture Round in 2010
Intellitect specializes in developing advanced water quality monitoring systems that enhance the ability of water companies to ensure the safety and quality of their products as they move through distribution networks. Their Insight system is designed to monitor drinking water, wastewater, and natural water resources by utilizing multiparameter instruments that gather and analyze various water quality metrics. This system provides real-time alerts and detailed information about potential quality issues, allowing users to quickly identify problems and respond effectively. By transmitting data to individual sensors and devices, Intellitect enables clients to access comprehensive statistics that support informed decision-making and help maintain high standards of water quality throughout the distribution process.

Intamac Systems

Venture Round in 2009
Intamac Systems Ltd. operates a cloud-based platform that facilitates connectivity to the Internet of Things (IoT), focusing on enhancing business models and customer engagement for original equipment manufacturers (OEMs) and product vendors in the connected home market. The company provides an Internet platform that connects various products and devices, enabling monitoring and control services accessible via mobile phones or the Internet. Its offerings include alarm monitoring, elderly care, flood and fire detection, camera monitoring, and environmental monitoring, along with a messaging service that alerts users to issues such as power failures and security breaches. Intamac also provides a full access license program, allowing companies to control the IoT software and develop custom solutions with reduced risk. Founded in 2000, Intamac is headquartered in Northampton, United Kingdom, with additional offices in Cambridge, UK, and Trivandrum, India.

Probe Scientific

Series A in 2009
Probe Scientific Ltd. is a private company based in Coventry, United Kingdom, specializing in the development of medical devices and diagnostic products aimed at improving healthcare. Founded in 1998, the company has established a significant product pipeline featuring innovative technologies designed to address clinical challenges. Key products include MicroEye, which enables continuous online blood sampling, ContinuMon, an external monitoring system for lactate and glucose levels, and NanoEye, a monitoring device intended for use in neonatal and pediatric intensive care units. Probe Scientific's automated blood sampling technology supports a variety of applications, including critical care, therapeutic drug monitoring, and clinical research, reinforcing its commitment to enhancing patient care and advancing medical practices.

Accutronics

Venture Round in 2009
Accutronics Ltd is a company based in Newcastle under Lyme, United Kingdom, specializing in the design, development, and manufacture of rechargeable batteries and chargers for portable and handheld electronic devices. Established in 2009, Accutronics focuses on creating custom-designed battery packs and smart battery technology for various sectors, including medical, defense, security, industrial electronics, and robotics. The company's products incorporate advanced features such as electronic fuel gauging and active safety systems, enabling original equipment manufacturers (OEMs) to produce smaller, lighter, and safer portable devices. Additionally, Accutronics distributes a range of standard smart batteries, chargers, and accessories through its partnership with Inspired Energy. As of 2016, Accutronics operates as a subsidiary of Ultralife Batteries (UK) Ltd.

Systems Integration (Trading) Limited

Private Equity Round in 2009
Systems Integration (Trading) Limited specializes in providing software and hardware solutions tailored for the food processing industry. The company offers a range of products under the Sistem 7 brand, including SHOP FLOOR DATA CAPTURE to eliminate manual data entry, SALES ORDER PROCESSING featuring an Explorer interface, and BONING HALL software that facilitates the issuance of stock for boning processes. Additional offerings include OUTER CASE MARKER for weighing and labeling products on the production line, DESPATCH & TRACKER for monitoring order dispatch statuses, and STOCK & TRACKER for managing inventory levels and shelf life. Furthermore, Systems Integration provides support services such as help desk assistance, remote diagnostics, software upgrades, and operational consultancy. Established in 1994, the company is located in Lichfield, United Kingdom.

Systems Integration

Venture Round in 2009
Systems Integration specializes in providing advanced hardware and software solutions tailored for the meat processing industry. The company combines extensive field experience with cutting-edge technology to enhance operational efficiency within organizations. Its offerings include enterprise resource planning (ERP) and manufacturing execution system (MES) software focused on regulatory compliance, margin improvement, and quality control. By delivering sector-specific software and tools for planning, quality assurance, and traceability, Systems Integration enables clients to streamline their supply chains, reduce waste, and ultimately improve profitability.

Monica Healthcare

Venture Round in 2009
Monica Healthcare specializes in the manufacturing and supply of advanced fetal monitoring devices aimed at improving obstetric care for midwives, labor and delivery nurses, and expectant mothers. The company’s flagship product, The Novii, is a single-use wireless patch system that monitors maternal heart rate, fetal heart rate, and uterine activity, enhancing the birthing experience. Additionally, Monica Healthcare develops a range of wearable devices that utilize innovative wireless technologies to provide accessible obstetric services both in hospitals and at home. The company also offers training, repairs, and support services for its products. Established in 2005 and headquartered in Nottingham, United Kingdom, with a location in Kennesaw, Georgia, Monica Healthcare operates as a subsidiary of GE Healthcare.

Warwick Effect Polymers

Venture Round in 2009
Warwick Effect Polymers Limited manufactures and markets complex polymers using living controlled radical polymerization.

Comply Serve

Venture Round in 2009
Comply Serve Limited is a software company based in Solihull, United Kingdom, specializing in assurance and compliance solutions for highly regulated industries, including rail, aviation, energy, and infrastructure. Founded in 2005, the company developed ComplyPro, a cloud-based platform designed for large-scale infrastructure projects. This platform facilitates compliance monitoring throughout the project lifecycle, ensuring that design, build, and delivery processes adhere to agreed specifications. ComplyPro promotes collaborative working between clients and their supply chains, enhancing governance over assurance processes. By enabling engineering and delivery teams to manage compliance effectively, the software helps project sponsors make informed decisions, ultimately reducing project failure risks and improving overall outcomes. As of November 2016, Comply Serve operates as a subsidiary of Bentley Systems, Incorporated.

Comply

Venture Round in 2009
Comply provides specialized, off-the-shelf scientific and process data management software products, and offers Professional Consulting Services to support and enhance Life Science companies in successfully meeting unique industry demands.

Oxford Biotherapeutics

Venture Round in 2009
Oxford BioTherapeutics Ltd is a biotechnology company specializing in the development of targeted antibody-drug conjugates for cancer treatment. Utilizing its proprietary OGAP platform, which is one of the largest human protein databases, the company identifies a range of validated and novel antigen targets from various cancer types. Its leading product, OBT076, is an antibody-drug conjugate aimed at treating high-risk HER2 negative breast cancer, as well as other solid tumors such as gastric, lung, bladder, and ovarian cancers. In addition to its cancer therapies, Oxford BioTherapeutics is also engaged in developing antibody-based treatments for acute myeloid leukemia. The company has formed strategic collaborations with prominent antibody firms to enhance its pipeline of novel therapeutics. Established in 2003 and based in Oxon, United Kingdom, with a presence in San Jose, California, Oxford BioTherapeutics aims to improve patient outcomes through innovative treatments and the integration of companion diagnostics into its development processes.

Key Technologies

Seed Round in 2008
Key Technologies Ltd. is a specialist engineering company based in Cradley Heath, United Kingdom, established in 2003. The company focuses on providing engineering solutions primarily within the Defense and Homeland Security sectors. It manufactures and supplies a range of products, including specialist ammunition, 12 gauge rounds, explosive ordnance disposal (EOD) equipment, and public order solutions, distributing these products globally. In addition to its manufacturing capabilities, Key Technologies engages in design, electronic manufacturing, and through-life system engineering services, offering comprehensive support throughout the lifecycle of its products.

4energy

Venture Round in 2008
4energy Ltd. develops energy cooling systems and platforms for telecommunications and equipment rooms.

4Energy

Venture Round in 2008
4energy, based in Nottingham, specializes in innovative cooling solutions that significantly enhance energy efficiency, achieving up to 50% savings compared to traditional cooling systems. The company has developed an IoT software platform that integrates data from various meters, regardless of vendor, to provide a centralized overview of utility usage. This platform is designed for application in industrial and commercial environments, including data centers, communication rooms, and base stations. By facilitating network-free cooling and demand-side response initiatives, 4energy's solutions aim to optimize energy consumption in the data center and telecommunications sectors.

Sight and Sound Technology

Acquisition in 2008
Sight and Sound Technology Limited is a UK-based company that specializes in distributing hardware and software solutions for individuals who are blind, visually impaired, or have learning and reading difficulties. Founded in 1982 and headquartered in Northampton, the company offers a wide range of products, including braille displays, electronic video magnifiers, screen readers, and talking barcode scanners. In addition to these products, Sight and Sound provides services such as audit and assessment, solution design, training, and ongoing customer support. The company caters to a diverse clientele, including individuals, charities, government entities, educational institutions, and corporations, and also sells its products online. With a focus on assistive technologies, Sight and Sound aims to empower users by enhancing their day-to-day activities and helping them realize their potential.

Oxford Biotherapeutics

Venture Round in 2008
Oxford BioTherapeutics Ltd is a biotechnology company specializing in the development of targeted antibody-drug conjugates for cancer treatment. Utilizing its proprietary OGAP platform, which is one of the largest human protein databases, the company identifies a range of validated and novel antigen targets from various cancer types. Its leading product, OBT076, is an antibody-drug conjugate aimed at treating high-risk HER2 negative breast cancer, as well as other solid tumors such as gastric, lung, bladder, and ovarian cancers. In addition to its cancer therapies, Oxford BioTherapeutics is also engaged in developing antibody-based treatments for acute myeloid leukemia. The company has formed strategic collaborations with prominent antibody firms to enhance its pipeline of novel therapeutics. Established in 2003 and based in Oxon, United Kingdom, with a presence in San Jose, California, Oxford BioTherapeutics aims to improve patient outcomes through innovative treatments and the integration of companion diagnostics into its development processes.

Silver Lining Solutions

Venture Round in 2008
Silver Lining Solutions Limited specializes in employee performance optimization software tailored for international call centers. The company’s innovative solutions enhance employee engagement and performance by identifying individual skills and knowledge, ensuring that customer inquiries are directed to the most qualified personnel. Their software suite includes tools for diagnosing performance issues, scheduling assessments, importing performance data, and generating customized development plans to address skill gaps. Additionally, it facilitates various training methods such as e-learning, coaching, and team meetings. Founded in 1999 and headquartered in Solihull, United Kingdom, Silver Lining Solutions also maintains offices in Asia Pacific and the United States. The company has established strategic partnerships with notable organizations in the telecommunications sector, enhancing its ability to deliver impactful solutions. As of February 2017, Silver Lining Solutions operates as a subsidiary of Genesys Telecommunications Laboratories, Inc.

Haemostatix

Venture Round in 2008
Haemostatix Ltd., founded in 2003 and based in Nottingham, United Kingdom, specializes in developing a peptide-based platform technology aimed at addressing surgical bleeding and advancing tissue repair and regenerative medicine. The company originated as a spin-out from the University of Leicester and was co-founded by Sarah Middleton and Professor Alison Goodall. Its product pipeline includes PeproStat, a coagulant applied directly to wounds to effectively manage bleeding during surgical procedures. Haemostatix also focuses on creating various forms of hemostats, including liquid and transparent gel formulations, which enhance the speed and safety of bleeding control for healthcare professionals. As of May 2016, Haemostatix operates as a subsidiary of Ergomed plc.

BWB Consulting

Private Equity Round in 2008
BWB Consulting is an integrated engineering and environmental consultancy that delivers multi-disciplinary engineering solutions to the property, development and construction industry. BWB Consulting provides over 70 services, in 15 sectors to an international client base. It offers building and built environment services ranging from designing new buildings to adapting, refurbishing, and maintaining existing building stocks; and from initial feasibility study to planning, detailed design, construction, routine maintenance, decommissioning, and demolition services for public and private sector development projects. Its environment services include advisory, investigative, design, and validation services relating to various aspects of the ground and water environment. The company also provides transport and infrastructure services, which include planning and designing multi-modal transport infrastructure. It serves industrial and manufacturing, education, retail, leisure and hospitality, residential, distribution, energy and carbon, retail, urban regeneration, commercial, health, public, culture and heritage, road and rail, finance and investment, and water environment sectors. The company was founded in 1990 and is based in Nottingham, United Kingdom. As of July 12, 2017, BWB Consulting Limited operates as a subsidiary of Construcciones y Auxiliar de Ferrocarriles, S.A.

Activ8 Intelligence

Venture Round in 2008
Activ8 Intelligence Limited specializes in providing human resources reporting, analytics, and predictive solutions aimed at enhancing workforce management and business outcomes. The company offers a range of services, including HR reporting tools that deliver key performance indicators, dashboards, and analytical reports. Its analytics solutions, such as doogle and trend analyzers, enable organizations to interpret data effectively. Additionally, Activ8 provides predictive solutions that facilitate workforce planning, recruitment, and talent management decisions. The company also offers human capital consultancy services, data analysis, and metrics design, helping organizations translate complex data into actionable insights. Established in 2005 and based in Farnsfield, United Kingdom, Activ8 Intelligence was previously known as active8 Human Resources Limited before rebranding in 2007. As of September 2016, it operates as a subsidiary of Liaison Financial Services Limited.

r2c Online

Seed Round in 2008
r2c Online Limited operates an online platform tailored for the road transport industry in Europe, facilitating compliance, quoting, authorization, and invoicing. This platform serves as a digital hub for vehicle manufacturers, dealers, repairers, workshops, fleet operators, and fleet management and leasing companies, enabling efficient communication and management of vehicle inspection and maintenance records. By offering a centralized system for storing and accessing service and compliance information, r2c Online supports small and medium-sized enterprises as well as corporate clients. Founded in 2003 and based in Sheffield, United Kingdom, r2c Online Limited has positioned itself as a key player in the digital fleet management space. The company has been a subsidiary of FleetCor Technologies, Inc. since April 2019.

SolarTech

Venture Round in 2008
SolarTech Ltd. specializes in the design and installation of renewable energy systems aimed at maximizing green energy usage and reducing greenhouse gas emissions. The company offers a comprehensive range of services, including the design, monitoring, supply, installation, and maintenance of various renewable energy solutions such as solar panels, biomass boilers, wind turbines, and heat pumps. By serving the domestic, commercial, and public sectors, SolarTech Ltd. enables its clients to adopt environmentally friendly practices and contribute to sustainability efforts.

Atlantic Link Limited

Venture Round in 2008
Atlantic Link Limited develops rapid e-learning training products which enable users to design and deliver professional on-line training to thousands of employees which would, in the past, have taken months to create at great cost. It offers Content Point, a remote authoring system that enables the development of e-learning courses; Capture Point, a capture tool for the automatic creation of online software training courses; and Knowledge point, a collaboration server and learning management system that provides course launch and tracking, results storage, student import, and user and author grouping functions. The company also specializes in project management, instructional design, branding and design, technical, and account management areas, as well as provides eLearning support and hosted solutions. It serves corporate clients, as well as government and higher education markets through a network of resellers globally. Atlantic Link Limited was founded in 2002 and is based in Nottingham, United Kingdom with an additional office in Atlanta, Georgia.

CellAura

Venture Round in 2008
CellAura Technologies, Ltd. specializes in providing innovative screening products for the drug discovery industry. Originating as a spin-out from the University of Nottingham, the company leverages expertise in synthetic chemistry and molecular pharmacology to develop high-quality fluorescent ligands targeting various receptors, including adenosine, beta-adrenergic, dopamine, histamine, and muscarinic receptors. In addition to its product offerings, CellAura provides a contract fluorescent ligand development and validation service, allowing for the synthesis of custom products accompanied by comprehensive pharmacological characterization. Based in Nottingham, United Kingdom, CellAura aims to enhance molecular pharmacology and imaging capabilities at the single-cell level.

Eden Luxury Group

Venture Round in 2008
Eden Luxury is a Chester-based travel brand that provides high end holidays through its Seasons in Style and Eden Collection.

L3 Technology

Venture Round in 2008
L3 Technology develops a point of care testing system for reading blood analytes from various samples. It offers a lipid profile testing system for measuring a multi-fraction lipid profile from a finger stick sample of blood, serum, or plasma. The company was incorporated in 2001 and is based in Coventry, United Kingdom. As of December 16, 2016, L3 Technology was acquired by Jupiter Diagnostics.

Abzena

Venture Round in 2008
Abzena is a biologics research partner that specializes in providing services and technologies for the development and manufacture of biopharmaceutical products globally, including in North America and Europe. The company focuses on biologics and antibody-drug conjugates (ADCs), offering solutions that span from early discovery to mid-phase biotherapeutic and bioconjugation drug development. Abzena's service offerings include antibody and protein engineering, developability assessment, immunogenicity assessment, and various bioassays and bioanalytics. Additionally, it provides expertise in ADC manufacturing and peptide synthesis. By serving biopharmaceutical companies and academic groups, Abzena aims to enhance the development of innovative treatments for patients. Established in 2014 and headquartered in Cambridge, United Kingdom, Abzena has positioned itself as a key player in the biopharmaceutical industry.

Synchro Software

Venture Round in 2007
Synchro Software Ltd. specializes in developing advanced digital construction software aimed at enhancing the management of complex construction projects. Founded in 2001 and headquartered in Birmingham, United Kingdom, with additional offices in the United States, the company offers a comprehensive suite of tools including a 4D building information modeling platform for visual planning and scheduling. Its flagship product, Synchro 4D, allows users to visualize projects in both 3D and 4D, enabling effective communication of resource properties and facilitating collaborative project management through its Synchro Server. The software is designed to optimize construction plans, ultimately improving safety, reliability, and productivity across various construction sectors, including commercial, civil, and residential projects. Synchro serves a diverse client base, from large corporations to local consultants, both in the UK and internationally. As of June 2018, it operates as a subsidiary of Bentley Systems, Incorporated.

Monica Healthcare

Venture Round in 2007
Monica Healthcare specializes in the manufacturing and supply of advanced fetal monitoring devices aimed at improving obstetric care for midwives, labor and delivery nurses, and expectant mothers. The company’s flagship product, The Novii, is a single-use wireless patch system that monitors maternal heart rate, fetal heart rate, and uterine activity, enhancing the birthing experience. Additionally, Monica Healthcare develops a range of wearable devices that utilize innovative wireless technologies to provide accessible obstetric services both in hospitals and at home. The company also offers training, repairs, and support services for its products. Established in 2005 and headquartered in Nottingham, United Kingdom, with a location in Kennesaw, Georgia, Monica Healthcare operates as a subsidiary of GE Healthcare.

Blackstar Amplification

Private Equity Round in 2007
Blackstar Amplification Limited is a UK-based company located in Northampton, specializing in the design and manufacture of innovative guitar amplifiers and effects pedals. Founded by four directors, all of whom are experienced musicians, the company combines over 50 years of expertise in guitar amplification design and production. Blackstar's product range includes valve overdrive pedals, hand-wired amplifiers, and amplifiers suitable for studio and practice use, all aimed at providing guitarists with exceptional tools for self-expression.

R5 Pharmaceuticals

Seed Round in 2007
R5 Pharmaceuticals Ltd. engages in the contract development and manufacture of clinical trials materials.

Critical Pharmaceuticals

Series B in 2007
Critical Pharmaceuticals Limited is a biotechnology company based in Nottingham, United Kingdom, that specializes in the development of biological drug products using innovative drug delivery technologies. Founded in 2002 by Professor Steve Howdle, the company focuses on non-invasive nasal delivery and sustained release formulations for proteins, peptides, and small molecules. Its proprietary technologies, CriticalSorb and CriticalMix, facilitate the nasal delivery of biologics and the manufacture of depot products that allow for infrequent injections. The company's product pipeline includes CP024, a nasal growth hormone for growth hormone deficiency; CP046, a nasal treatment for osteoporosis; and CP057, a sustained-release formulation of Bevacizumab for age-related macular degeneration, among others. However, as of July 31, 2017, Critical Pharmaceuticals Limited has entered liquidation.

Oxford Biotherapeutics

Venture Round in 2007
Oxford BioTherapeutics Ltd is a biotechnology company specializing in the development of targeted antibody-drug conjugates for cancer treatment. Utilizing its proprietary OGAP platform, which is one of the largest human protein databases, the company identifies a range of validated and novel antigen targets from various cancer types. Its leading product, OBT076, is an antibody-drug conjugate aimed at treating high-risk HER2 negative breast cancer, as well as other solid tumors such as gastric, lung, bladder, and ovarian cancers. In addition to its cancer therapies, Oxford BioTherapeutics is also engaged in developing antibody-based treatments for acute myeloid leukemia. The company has formed strategic collaborations with prominent antibody firms to enhance its pipeline of novel therapeutics. Established in 2003 and based in Oxon, United Kingdom, with a presence in San Jose, California, Oxford BioTherapeutics aims to improve patient outcomes through innovative treatments and the integration of companion diagnostics into its development processes.

Anaxsys

Venture Round in 2007
Anaxsys Technology is a medical device company specializing in the development and marketing of respiratory devices aimed at monitoring and screening respiratory conditions such as asthma, lung cancer, and sleep apnea. Founded in 2002 and based in Send, United Kingdom, the company offers products like respiR8, a continuous respiratory rate counter that helps provide early indications of patient deterioration. Anaxsys's devices are designed to enhance patient safety by enabling healthcare professionals to monitor respiratory rates in post-operative, trauma, and emergency procedure patients, thereby facilitating early detection of respiratory illnesses. The company was previously known as Asthma Alert Limited before rebranding in 2006.

Michelson Diagnostics

Seed Round in 2007
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

Zysis

Venture Round in 2007
Zysis Limited is a pharmaceutical company focused on developing therapies for central nervous system disorders, aiming to enhance the quality of life for individuals affected by these conditions. The company is currently advancing two treatments: a once-weekly oral tablet designed for the management of psychotic conditions and as an adjunctive therapy for major depressive disorder, and a once-daily formulation targeting specialty anxiety disorders, including panic disorders and post-traumatic stress disorder. Through its research and development efforts, Zysis seeks to provide innovative drug solutions that enable healthcare professionals to deliver improved treatment options for their patients.

Whelan Refining

Venture Round in 2006
Whelan Refining Ltd recycles waste oil to produce base oil - the base for all industrial and automotive lubricants. It re-refines 50,000 tonnes per annum of used oils to produce a high-quality group I base oil for sale to the lubricant manufacturing industry. Whelan Refining was founded in 2005 and is based in Stoke-on-Trent, UK.

David Holmes BMW

Private Equity Round in 2006
Sytner Group Limited operates as a new and used car dealership company.

Critical Pharmaceuticals

Venture Round in 2005
Critical Pharmaceuticals Limited is a biotechnology company based in Nottingham, United Kingdom, that specializes in the development of biological drug products using innovative drug delivery technologies. Founded in 2002 by Professor Steve Howdle, the company focuses on non-invasive nasal delivery and sustained release formulations for proteins, peptides, and small molecules. Its proprietary technologies, CriticalSorb and CriticalMix, facilitate the nasal delivery of biologics and the manufacture of depot products that allow for infrequent injections. The company's product pipeline includes CP024, a nasal growth hormone for growth hormone deficiency; CP046, a nasal treatment for osteoporosis; and CP057, a sustained-release formulation of Bevacizumab for age-related macular degeneration, among others. However, as of July 31, 2017, Critical Pharmaceuticals Limited has entered liquidation.

Monica Healthcare

Seed Round in 2005
Monica Healthcare specializes in the manufacturing and supply of advanced fetal monitoring devices aimed at improving obstetric care for midwives, labor and delivery nurses, and expectant mothers. The company’s flagship product, The Novii, is a single-use wireless patch system that monitors maternal heart rate, fetal heart rate, and uterine activity, enhancing the birthing experience. Additionally, Monica Healthcare develops a range of wearable devices that utilize innovative wireless technologies to provide accessible obstetric services both in hospitals and at home. The company also offers training, repairs, and support services for its products. Established in 2005 and headquartered in Nottingham, United Kingdom, with a location in Kennesaw, Georgia, Monica Healthcare operates as a subsidiary of GE Healthcare.

Ergomed

Venture Round in 2005
Ergomed plc is a UK-based company specializing in providing drug development services to the pharmaceutical and biotechnology industries. It operates through two primary segments: Clinical Research Services and Pharmacovigilance. The Clinical Research Services segment offers a range of clinical development services, catering to both major pharmaceutical companies and smaller drug developers. The Pharmacovigilance segment focuses on monitoring drug safety and providing medical information services. Additionally, Ergomed has a Co-Development Business, which involves partnerships with pharmaceutical and biotech companies to develop new drugs, allowing the company to earn revenue from milestones and product sales associated with these drug assets. Overall, Ergomed is dedicated to supporting the drug development process while ensuring safety and compliance within the healthcare sector.

Demon Tweeks

Acquisition in 2004
Demon Tweeks is a retailer specializing in high-performance equipment and accessories for motorsport competitors, car tuners, and motorcycle enthusiasts. The company offers a wide range of motor parts and equipment, catering to the needs of both amateur and professional users in the automotive and motorsport industries. Through its extensive product offerings, Demon Tweeks serves as a key resource for individuals looking to enhance their vehicles' performance and aesthetics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.